ICFs – UK and US Clinical Considerations – Hosted by Faber

Jodi is the leader of Faber’s clinical development practice group. In addition to her client work, she provides training and oversight for attorneys’ and contract specialists’ handling of contract matters within the clinical development group.

Gina is a skilled transactional lawyer who counsels life sciences clients in structuring, drafting, and negotiating domestic and cross-border transactions for the research and development of drug, medical device, gene therapy, cell therapy, and diagnostic products.

Marc helps clients to evaluate and manage data protection and cyber risk in cross-border compliance programs, in technology projects involving the development of machine learning/artificial intelligence, Internet of Things, cloud applications, in life sciences and medical device projects covering healthcare apps, remote diagnostics, clinical trials and investigations and genomic research, and in the financial services sector across the lifecycle of product development and FinTech applications.

Alex is passionate about the life sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience, including as GC of a biopharmaceutical company, and brings 25 years’ experience advising clients in the sector. Alex advises clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products.